Rociletinib hydrobromide

AbMole BioScience

Rociletinib hydrobromide

9

1446700-26-0

Chemical

Research Use Only

C27H29BrF3N7O3

636.46

Rociletinib hydrobromide (CO-1686 hydrobromide) is an orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M, and the Ki values for EGFRL858R/T790M and EGFRWT are 21.5 nM and 303.3 nM, respectively.

2-8°C, dry, sealed

12352200